Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
123
Journal Issue
3
Pages
340
Date Issued
2024-03
Author(s)
Lin, Pin-Hung
Cheng, Yu-Chen
Wu, Yu-Yun
Abstract
Information on the protein-based severe acute respiratory syndrome (SARS-CoV-2) vaccine-NVX-CoV2373 (Novavax), as a heterologous booster remains limited. We investigated the immunogenicity and adverse events of NVX-CoV2373 as a second booster and compared them with those of mRNA vaccines in healthy adults.
Subjects
Coronavirus disease 2019 (COVID-19); Immune response; Messenger RNA vaccine; Protein-based vaccine; Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)
SDGs
Type
journal article